Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Regeneron Pharmaceuticals
The duration of the study period for each participant was up to 14 weeks, including a screening period up to 2 weeks, and 12-week follow-up after the injection.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Moderate to severe abdominal pain due to chronic pancreatitis of at least 6 months duration.
You may not be if
Mild pain on the Pain Intensity-Numeric Rating Scale \[PI-NRS\] at screening and randomization visits;
Narcotic addiction;
Recent pancreatic surgical or endoscopic intervention for chronic pancreatitis pain;
Unwillingness to use study-defined rescue analgesia exclusively.
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Clareo Health | Single Injection of REGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain
